← ANALYST RATINGS · TIPRANKS
Ashland (ASH): analyst forecast and price target
Analyst consensus
Strong Buy5 Buy0 Hold0 Sell
Ratings of 5 analysts in the last 3 months · top analysts only12-month forecast
Based on 5 price targets given in the last 3 months, the average target is $79.00, the highest $83.00, the lowest $75.00. The average is +11.0% from the last price of $71.15.
Analyst ratings 12
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Michael Sison★★★★★★★★★★#11471 · hits 43% · avg −2.5% | Wells Fargo | $70.00 → $75.00+7.1% | Hold | +5.4% | Assigned | 15.10.26on TipRanks Oct 16 05:15 | +0.1%next day +0.5% | ↗ |
| Joshua Spector★★★★★★★★★★#3207 · hits 53% · avg +3.3% | UBS | $83.00 → $80.00−3.6% | Buy | +12.4% | Reiterated | 05.10.26on TipRanks 06:00 | −1.7%next day +2.6% · 5 days +2.5% | ↗ |
| AI xAi Chemicals - SpecialtyxAI Grok-4 | TipRanks - xAI | $77.00 → $70.00−9.1% | Hold | −1.6% | Reiterated | 26.09.26on TipRanks Sep 25 23:05 | — | |
| AI DeepSeek Chemicals - SpecialtyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $78.00 → $69.00−11.5% | Hold | −3.0% | Reiterated | 26.09.26on TipRanks Sep 25 23:05 | — | |
| AI OpenAI Chemicals - SpecialtyOpenAI 5.2 | TipRanks - OpenAI | $76.00 → $71.00−6.6% | Hold | −0.2% | Reiterated | 26.09.26on TipRanks Sep 25 23:05 | — | |
| AI Anthropic Chemicals - SpecialtyAnthropic Opus-4.6 | TipRanks - Anthropic | $73.00 → $68.00−6.8% | Hold | −4.4% | Reiterated | 26.09.26on TipRanks Sep 25 23:05 | — | |
| AI Google Chemicals - SpecialtyGemini 3.1Pro | TipRanks - Google | $79.00 → $73.00−7.6% | Hold | +2.6% | Reiterated | 26.09.26on TipRanks Sep 25 23:05 | — | |
| AI PerPlexity Chemicals - SpecialtyPerPlexity SonarPro | TipRanks - PerPlexity | $74.00 → $71.00−4.1% | Hold | −0.2% | Reiterated | 26.09.26on TipRanks Sep 25 23:05 | — | |
| Unknown Analyst | Jefferies | $88.00 | Buy | +23.7% | Reiterated | 22.09.26on TipRanks Sep 25 23:05 | +0.9%next day −0.2% · 5 days −0.6% | ↗ |
| John McNulty★★★★★★★★★★#2310 · hits 54% · avg +4.6% | BMO Capital | $75.00 | Buy | +5.4% | Reiterated | 21.09.26on TipRanks Sep 22 07:10 | −1.6%next day +0.9% · 5 days −0.4% | ↗ |
| Alexandra Yates★★★★★★★★★★#1237 · hits 85% · avg +33.3% | Argus Research | $64.00 → $80.00+25.0% | Buy | +12.4% | Reiterated | 21.08.26on TipRanks Aug 30 08:08 | −0.6%next day +1.7% · 5 days +1.9% | ↗ |
| Chris Parkinson★★★★★★★★★★#1612 · hits 59% · avg +6.3% | Wolfe Research | $78.00 → $83.00+6.4% | Buy | +16.7% | Reiterated | 10.08.26on TipRanks 08:35 | −1.3%next day −0.8% · 5 days −1.6% | ↗ |
| Steven Haynes★★★★★★★★★★#10056 · hits 44% · avg −6.5% | Morgan Stanley | $58.00 → $78.00+34.5% | Hold | +9.6% | Assigned | 06.08.26on TipRanks 08:20 | +1.2%next day +4.9% · 5 days 0.0% | ↗ |
| David Begleiter★★★★★★★★★★#4870 · hits 52% · avg +1.4% | Deutsche Bank | $74.00 → $85.00+14.9% | Buy | +19.5% | Assigned | 31.07.26on TipRanks 09:00 | −0.8%next day −2.6% · 5 days +1.8% | ↗ |
| Eric Boyes★★★★★★★★★★#5799 · hits 57% · avg +3.2% | Evercore ISI | $60.00 → $73.00+21.7% | Hold | +2.6% | Reiterated | 30.07.26on TipRanks 08:46 | −1.9%next day −0.8% · 5 days −4.0% | ↗ |
| Jeffrey Zekauskas★★★★★★★★★★#2991 · hits 53% · avg +3.3% | J.P. Morgan | $75.00 → $80.00+6.7% | Buy | +12.4% | Assigned | 30.07.26on TipRanks 07:31 | −1.9%next day −0.8% · 5 days −4.0% | ↗ |
| John Roberts CFA★★★★★★★★★★#651 · hits 62% · avg +10.3% | Mizuho Securities | $75.00 → $77.00+2.7% | Buy | +8.2% | Reiterated | 29.07.26on TipRanks 07:57 | +8.6%next day −1.9% · 5 days −7.1% | ↗ |
| Michael Harrison CFA★★★★★★★★★★#4322 · hits 56% · avg +2.8% | Seaport Global | $75.00 → $90.00+20.0% | Buy | +26.5% | Reiterated | 14.06.26on TipRanks 09:30 | −1.1%next day −0.7% · 5 days +0.3% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Ashland
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $79.27 at a price of $67.92 (+16.7%); now: $79.45 at $71.15 (+11.7%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 5 | 10 | 11 | 10 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 10.11.26 (Q4 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $1.28 (from $1.00 to $1.35). Last quarter: $1.02.
Sales
Next quarter’s sales estimate — $502M (from $495M to $507M). Last quarter: $497M.
Best top-analyst consensus in the sector · Basicmaterials
About Ashland
- CEO: Guillermo Novo
- Employees: 2,900
- 8145 Blazer Drive, Wilmington, DE, 19808, US
- www.ashland.com
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, constr
Data from the stock’s TipRanks forecast page, read 60 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗